Nasus Pharma Ltd (NSRX) PT Lowered to $18 at Citizens: NS002 Likely Best-in-Class

March 26, 2026 4:44 AM

Citizens analyst Jason Butler lowered the price target on Nasus Pharma Ltd (NYSE: NSRX) to $18.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found